FSE$FMS
Fresenius Medical Care AG & Co. KGAA · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
FMS Q2 2024 — n/d revenue, 30.00 EPS
You should read the following discussion and analysis of the results of operations of the Company and its subsidiaries in conjunction with our unaudited interim consoli. Fresenius Medical Care AG & Co. KGAA reported Q2 2024 results. Diluted EPS came in at 30.00. Headline numbers extracted from the Form 6-K press release; narrative is light because this row was processed without an LLM call.
- Diluted EPS: 30.00.
- Operating income: €1K.
- Filed on Form 6-K (accession 0001104659-24-083777).
Headline financials
Revenue & EPS history
Fresenius Medical Care · Revenue · Quarterly
$5.13B
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2024
+0.1%
Avg return
Earnings day
-1.3%
Avg return
5 days after
+0.2%
Avg return
30 days after
16%
11 / 67 earnings
Positive
+23.1%
Q1 2011
Best reaction
-8.9%
Q1 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | -6.7% | -1.3% | +55.7% | |
| Q4 2024 | +0.0% | +3.9% | +5.3% | |
| Q2 2024 | +0.0% | -6.4% | -4.9% | |
| Q4 2023 | +6.7% | -8.2% | -9.7% | |
| Q3 2023 | +0.0% | +2.0% | +24.6% | |
| Q2 2023 | +0.0% | +0.2% | -7.9% | |
| Q1 2023 | -0.5% | +1.3% | +0.2% | |
| Q4 2022 | +6.9% | +0.0% | +1.6% | |
| Q3 2022 | +0.0% | +7.9% | +11.3% | |
| Q2 2022 | +0.0% | -18.6% | -24.4% | |
| Q1 2022 | -8.9% | -4.7% | -9.3% | |
| Q4 2021 | +0.0% | -2.1% | -2.5% | |
| Q3 2021 | -4.6% | +4.3% | -10.8% | |
| Q2 2021 | +0.0% | -3.2% | -5.7% | |
| Q1 2021 | +0.0% | -1.0% | +3.6% | |
| Q4 2020 | +0.0% | -3.1% | +3.5% | |
| Q3 2020 | +0.0% | -2.5% | +6.5% | |
| Q2 2020 | +0.0% | -4.9% | -9.2% | |
| Q1 2020 | +0.0% | +2.9% | +13.6% | |
| Q4 2019 | +3.1% | -4.2% | -28.6% | |
| Q3 2019 | +3.3% | +10.5% | +10.8% | |
| Q2 2019 | -8.8% | -10.1% | -11.5% | |
| Q1 2019 | +6.7% | -1.8% | -12.6% | |
| Q4 2018 | +0.0% | +3.8% | +0.5% | |
| Q3 2018 | -1.9% | -2.8% | +4.0% | |
| Q2 2018 | +0.0% | +0.9% | +8.3% | |
| Q1 2018 | +0.0% | -2.5% | -3.6% | |
| Q4 2017 | -2.5% | -5.8% | -6.7% | |
| Q3 2017 | -0.5% | +0.2% | +2.6% | |
| Q2 2017 | +0.0% | -1.3% | -0.1% | |
| Q1 2017 | +0.0% | +1.5% | +6.7% | |
| Q4 2016 | +0.0% | +0.8% | +1.8% | |
| Q3 2016 | +0.0% | +0.5% | -2.5% | |
| Q2 2016 | +2.6% | +1.0% | -4.5% | |
| Q1 2016 | -3.1% | — | — | |
| Q4 2015 | +1.1% | — | — | |
| Q3 2015 | +5.4% | — | — | |
| Q2 2015 | -4.7% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q4 2014 | +7.0% | — | — | |
| Q3 2014 | +0.0% | — | — | |
| Q2 2014 | -4.5% | — | — | |
| Q1 2014 | +0.0% | — | — | |
| Q4 2012 | -6.4% | — | — | |
| Q4 2013 | -6.4% | — | — | |
| Q3 2013 | +0.0% | — | — | |
| Q2 2013 | -3.7% | — | — | |
| Q1 2013 | +0.0% | — | — | |
| Q3 2012 | +0.0% | — | — | |
| Q2 2012 | +0.0% | — | — | |
| Q1 2012 | -0.6% | — | — | |
| Q4 2011 | +1.4% | — | — | |
| Q3 2011 | +0.0% | — | — | |
| Q2 2011 | +0.0% | — | — | |
| Q1 2011 | +23.1% | — | — | |
| Q4 2010 | +0.0% | — | — | |
| Q3 2010 | +0.0% | — | — | |
| Q2 2010 | +0.0% | — | — | |
| Q1 2010 | +0.0% | — | — | |
| Q1 2009 | +0.0% | — | — | |
| Q4 2009 | +0.0% | — | — | |
| Q4 2007 | +0.0% | — | — | |
| Q3 2008 | +0.0% | — | — | |
| Q3 2009 | +0.0% | — | — | |
| Q2 2008 | +0.0% | — | — | |
| Q4 2008 | +0.0% | — | — | |
| Q2 2009 | +0.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro